Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12091463 Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Erik Depla0

Lennart Zabeau0

Jan Tavernier0

Nikolai Kley0

Date of Patent

September 17, 2024

0

Patent Application Number

166362500

Date Filed

August 8, 2018

0

Patent Citations

US Patent 9534056 Engineered TAA antibody-TNFSF member ligand fusion molecules

0

US Patent 9732135 Targeting of human interferon antagonists

0

US Patent 9878014 Targeted human-interferon fusion proteins

0

US Patent 9914759 Targeted modified TNF family members

0

US Patent 9932409 Targeted modified IL-1 family members

0

US Patent 10034919 Targeted human-interferon fusion proteins

0

US Patent 10035835 Targeted modified TNF family members

0

US Patent 10072059 Targeting of human interferon antagonists

0

...

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

0

...

Patent abstract

The present invention relates, in part, to agents that bind Clec9A and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12091463 Clec9A binding agents comprising a recombinant heavy-chain only antibody (VHH)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool